Tag: Matthew J. Frank

Home / Matthew J. Frank

Categories

High CR rates are overcome by CD22-directed CAR T-Cell therapy against CD19 relapse in LBCL

In February 2023, a phase 1 trial at a single institution found that it was safe and possible for people with heavily pretreated large B-cell lymphoma (LBCL) to use CD22-directed chimeric antigen rec...
matthew-j-frank

Scan the code